BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1967317)

  • 1. Histamine H3 ligands: just pharmacological tools or potential therapeutic agents?
    Timmerman H
    J Med Chem; 1990 Jan; 33(1):4-11. PubMed ID: 1967317
    [No Abstract]   [Full Text] [Related]  

  • 2. H3 receptor antagonists/inverse agonists as anti-obesity agents.
    Hancock AA
    Curr Opin Investig Drugs; 2003 Oct; 4(10):1190-7. PubMed ID: 14649210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in histamine pharmacology reveal new drug targets.
    Chazot PL
    Br J Pharmacol; 2009 May; 157(1):1-3. PubMed ID: 19413566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histamine as a neuroregulator.
    Prell GD; Green JP
    Annu Rev Neurosci; 1986; 9():209-54. PubMed ID: 2871797
    [No Abstract]   [Full Text] [Related]  

  • 5. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor.
    Arrang JM; Garbarg M; Schwartz JC
    Nature; 1983 Apr; 302(5911):832-7. PubMed ID: 6188956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly potent and selective ligands for histamine H3-receptors.
    Arrang JM; Garbarg M; Lancelot JC; Lecomte JM; Pollard H; Robba M; Schunack W; Schwartz JC
    Nature; 1987 May 14-20; 327(6118):117-23. PubMed ID: 3033516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of histamine H3-antagonists on human leukocytes.
    Kleine-Tebbe J; Schramm J; Bolz M; Lipp R; Schunack W; Kunkel G
    Agents Actions; 1990 Apr; 30(1-2):137-9. PubMed ID: 1695434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New development of histamine research on the inflammation. Foreword].
    Akagi M; Fukui H
    Yakugaku Zasshi; 2011 Feb; 131(2):169. PubMed ID: 21297356
    [No Abstract]   [Full Text] [Related]  

  • 9. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
    Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
    J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible roles of brain histamine H3 receptors and the pharmacology of its ligands].
    Onodera K; Watanabe T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):87-102. PubMed ID: 7796325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H3 receptors and sleep-wake regulation.
    Lin JS; Sergeeva OA; Haas HL
    J Pharmacol Exp Ther; 2011 Jan; 336(1):17-23. PubMed ID: 20864502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum.
    Taylor SJ; Kilpatrick GJ
    Br J Pharmacol; 1992 Mar; 105(3):667-74. PubMed ID: 1352720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel class (H3) of histamine receptors on perivascular nerve terminals.
    Ishikawa S; Sperelakis N
    Nature; 1987 May 14-20; 327(6118):158-60. PubMed ID: 3033517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future antihistamines: histamine H3 and H4 receptor ligands.
    Yu F; Bonaventure P; Thurmond RL
    Adv Exp Med Biol; 2010; 709():125-40. PubMed ID: 21618893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histamine H3 receptor: pharmacology and potential therapeutic applications.
    Garbarg M; Schwartz JC
    Ann Fr Anesth Reanim; 1993; 12(2):114-5. PubMed ID: 8368582
    [No Abstract]   [Full Text] [Related]  

  • 16. Histamine receptors: an overview.
    Parsons ME
    Scand J Gastroenterol Suppl; 1991; 180():46-52. PubMed ID: 1675026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histamine H3 receptor as a novel therapeutic target for cognitive and sleep disorders.
    Passani MB; Lin JS; Hancock A; Crochet S; Blandina P
    Trends Pharmacol Sci; 2004 Dec; 25(12):618-25. PubMed ID: 15530639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal histamine and its receptors: implication of the pharmacological treatment of obesity.
    Masaki T; Yoshimatsu H
    Curr Med Chem; 2010; 17(36):4587-92. PubMed ID: 21062248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histamine agonists and antagonists.
    Timmerman H
    Acta Otolaryngol Suppl; 1991; 479():5-11. PubMed ID: 2068941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts of histamine actions through H1 and H2 receptors.
    Summers RJ; Kaliner M
    Compr Ther; 1982 Mar; 8(3):6-16. PubMed ID: 7067399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.